Latest Breaking News On - Stern ir inc - Page 1 : vimarsana.com

Decibel Therapeutics, Inc : Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

Decibel Therapeutics, Inc : Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesChris raileyLaurence reidJulie seidelCommittee on orphan medicinal productsCompany phaseRegeneron pharmaceuticals incRegeneron pharmaceuticalsEuropean medicines agencyDrug administrationDevelopment expensesHearing loss programStern ir incExchange commissionTherapy designationChief executive officer

Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLaurence reidChris raileyJulie seidelHearing loss programStern ir incRegeneron pharmaceuticalsDevelopment expensesCommittee on orphan medicinal productsRegeneron pharmaceuticals incExchange commissionEuropean medicines agencyCompany phaseDrug administrationTherapy designationChief executive officer

Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss .

United statesChris raileyJulie seidelJohn leeAmerican society of clinical oncologyStern ir incExchange commissionAmerican societyClinical oncologyAnnual meetingChief development officerNeck cancerMetastatic diseaseDecibel therapeuticsPrivate securities litigation reform actQuarterly report

Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn leeChris raileyJulie seidelExchange commissionStern ir incAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingChief development officerNeck cancerMetastatic diseaseDecibel therapeuticsPrivate securities litigation reform actQuarterly report

Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss associated with cisplatin chemotherapyBOSTON, June 01, 2023 Decibel. | June 10, 2023

United statesJulie seidelChris raileyJohn leeExchange commissionStern ir incAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingChief development officerNeck cancerMetastatic diseaseDecibel therapeuticsPrivate securities litigation reform actQuarterly report